Journal of Health Economics and Outcomes Research
@journalheor.bsky.social
An international high-quality, open-access journal covering all fields and methodologies related to health economics and outcomes research. Indexed in PubMed, PubMed Central (PMC), Web of Science Emerging Sources Citation Index, DOAJ, Google Scholar.
In a study using real-world data, Black patients with #mCSPC treated with #apalutamide achieved earlier and higher deep PSA responses than those receiving #abiraterone acetate, suggesting improved outcomes in an understudied population. jheor.org/article/151273 #HEOR #prostatecancer
December 30, 2025 at 2:22 PM
In a study using real-world data, Black patients with #mCSPC treated with #apalutamide achieved earlier and higher deep PSA responses than those receiving #abiraterone acetate, suggesting improved outcomes in an understudied population. jheor.org/article/151273 #HEOR #prostatecancer
JHEOR extends its deepest appreciation to the peer reviewers who invested their time and expertise into providing feedback on the scores of manuscripts we received in 2025. #peerreview #HEOR
Interested in reviewing? Learn more at jheor.org/pages/157-fo...
Interested in reviewing? Learn more at jheor.org/pages/157-fo...
December 29, 2025 at 4:08 PM
JHEOR extends its deepest appreciation to the peer reviewers who invested their time and expertise into providing feedback on the scores of manuscripts we received in 2025. #peerreview #HEOR
Interested in reviewing? Learn more at jheor.org/pages/157-fo...
Interested in reviewing? Learn more at jheor.org/pages/157-fo...
New study highlights first national estimate of the economic burden of #RSV infection in #Colombia, highlighting high costs in infants and older adults and supporting targeted prevention and policy planning. #HEOR #prevention #economics
December 19, 2025 at 4:32 PM
New study highlights first national estimate of the economic burden of #RSV infection in #Colombia, highlighting high costs in infants and older adults and supporting targeted prevention and policy planning. #HEOR #prevention #economics
New study estimates the substantial economic burden of #alopecia areata in Saudi Arabia, showing high societal costs driven mainly by productivity loss, especially in severe and refractory disease. #HEOR jheor.org/article/151864
December 19, 2025 at 3:02 PM
New study estimates the substantial economic burden of #alopecia areata in Saudi Arabia, showing high societal costs driven mainly by productivity loss, especially in severe and refractory disease. #HEOR jheor.org/article/151864
In a real-world study of Black patients with metastatic prostate cancer, #apalutamide produced earlier and deeper PSA responses than #abiraterone acetate, highlighting potential clinical benefits in an understudied population. jheor.org/article/146844 #HEOR #ProstateCancer #BlackPatients
December 16, 2025 at 7:40 PM
In a real-world study of Black patients with metastatic prostate cancer, #apalutamide produced earlier and deeper PSA responses than #abiraterone acetate, highlighting potential clinical benefits in an understudied population. jheor.org/article/146844 #HEOR #ProstateCancer #BlackPatients
New study modeled and compared the carbon emissions of atrial fibrillation ablation techniques, showing pulsed field ablation produces substantially lower CO₂ emissions than cryoablation or radiofrequency ablation. #HEOR #AtrialFibrillation #CO2emissions
December 15, 2025 at 2:55 PM
New study modeled and compared the carbon emissions of atrial fibrillation ablation techniques, showing pulsed field ablation produces substantially lower CO₂ emissions than cryoablation or radiofrequency ablation. #HEOR #AtrialFibrillation #CO2emissions
Reposted by Journal of Health Economics and Outcomes Research
Recently approved RSV prevention therapies may be next FDA target
A representative from Sanofi told Reuters that the safety of Beyfortus has been repeatedly shown in over 50 studies.
www.cidrap.umn.edu/r...
Photo:Jon Works/Flickr cc
A representative from Sanofi told Reuters that the safety of Beyfortus has been repeatedly shown in over 50 studies.
www.cidrap.umn.edu/r...
Photo:Jon Works/Flickr cc
December 9, 2025 at 8:51 PM
Recently approved RSV prevention therapies may be next FDA target
A representative from Sanofi told Reuters that the safety of Beyfortus has been repeatedly shown in over 50 studies.
www.cidrap.umn.edu/r...
Photo:Jon Works/Flickr cc
A representative from Sanofi told Reuters that the safety of Beyfortus has been repeatedly shown in over 50 studies.
www.cidrap.umn.edu/r...
Photo:Jon Works/Flickr cc
Gold medals to Boston, Chicago, Denver, Minneapolis, New Orleans, Portland, San Antonio, and St. Louis.
@cityhealth.bsky.social has released its 9th annual assessment of 12 health policies of the 75 largest U.S. cities. This year, ~47.6 million people live in a city that has earned an overall medal. now.temple.edu/news/2025-12...
December 9, 2025 at 5:14 PM
Gold medals to Boston, Chicago, Denver, Minneapolis, New Orleans, Portland, San Antonio, and St. Louis.
Reposted by Journal of Health Economics and Outcomes Research
💬 Viewpoint: The Joint Commission and Coalition for Health AI have issued guidance on responsible #AI use in health care, but without a unified evaluation system, US hospitals face liability and efficiency challenges as AI adoption expands.
ja.ma/4ro7Moj
ja.ma/4ro7Moj
December 3, 2025 at 5:15 PM
💬 Viewpoint: The Joint Commission and Coalition for Health AI have issued guidance on responsible #AI use in health care, but without a unified evaluation system, US hospitals face liability and efficiency challenges as AI adoption expands.
ja.ma/4ro7Moj
ja.ma/4ro7Moj
Reposted by Journal of Health Economics and Outcomes Research
Global #whooping cough resurgence after COVID lull may point to need for better vaccines
Despite sustained high vaccine coverage, outbreaks continue to occur every 3 to 5 years in some countries.
www.cidrap.umn.edu/p...
Despite sustained high vaccine coverage, outbreaks continue to occur every 3 to 5 years in some countries.
www.cidrap.umn.edu/p...
December 3, 2025 at 5:41 PM
Global #whooping cough resurgence after COVID lull may point to need for better vaccines
Despite sustained high vaccine coverage, outbreaks continue to occur every 3 to 5 years in some countries.
www.cidrap.umn.edu/p...
Despite sustained high vaccine coverage, outbreaks continue to occur every 3 to 5 years in some countries.
www.cidrap.umn.edu/p...
Reposted by Journal of Health Economics and Outcomes Research
Use of DMARDs for RA was markedly lower among all major racial-ethnic minority groups in the U.S. compared with white patients, analysis of federal survey data indicated, even after adjusting for income, education, & other factors. @uressien.bsky.social
www.medpagetoday.com/rheumatology...
www.medpagetoday.com/rheumatology...
Standard-of-Care Treatment for Rheumatoid Arthritis Lags for Minority Groups
Shockingly low rates of DMARD use compared with white patients in federal data
www.medpagetoday.com
December 3, 2025 at 7:37 PM
Use of DMARDs for RA was markedly lower among all major racial-ethnic minority groups in the U.S. compared with white patients, analysis of federal survey data indicated, even after adjusting for income, education, & other factors. @uressien.bsky.social
www.medpagetoday.com/rheumatology...
www.medpagetoday.com/rheumatology...
New study examines whether QALY-based severity measures align with Japan’s HTA policies, identifying mismatches and potential for improved decision-making. #HEOR #Japan #HTA #HealthTechnologyAssessment #QALYs
December 2, 2025 at 2:59 PM
New study examines whether QALY-based severity measures align with Japan’s HTA policies, identifying mismatches and potential for improved decision-making. #HEOR #Japan #HTA #HealthTechnologyAssessment #QALYs
Timing may be key to effective cancer treatments.
Timing may be key to effective cancer treatments
Researchers at Washington University in St. Louis find the timing of biopsy can affect how doctors diagnose tumors and when those cancers may be more sensitive to chemotherapy.
source.washu.edu
November 21, 2025 at 3:47 PM
Timing may be key to effective cancer treatments.
Reposted by Journal of Health Economics and Outcomes Research
The CDC changed its website on Wednesday to suggest there may be a link between vaccines and autism, and experts are sounding the alarm. 🚨⬇️
November 20, 2025 at 9:51 PM
The CDC changed its website on Wednesday to suggest there may be a link between vaccines and autism, and experts are sounding the alarm. 🚨⬇️
New study uses simulation modeling to show how forecasting high-incidence Lyme years and deploying targeted public health interventions can significantly reduce disease cases and societal costs. #HEOR #LymeDisease #PublicHealth #SimulationModeling
November 20, 2025 at 6:03 PM
New study uses simulation modeling to show how forecasting high-incidence Lyme years and deploying targeted public health interventions can significantly reduce disease cases and societal costs. #HEOR #LymeDisease #PublicHealth #SimulationModeling
How effectively do the EQ-TIPS-3L and PedsQL instruments capture health-related quality of life in infants and toddlers aged 0–4 years? New study explores the performance of these measures. #HEOR #HRQoL #pediatrics
November 17, 2025 at 9:57 PM
How effectively do the EQ-TIPS-3L and PedsQL instruments capture health-related quality of life in infants and toddlers aged 0–4 years? New study explores the performance of these measures. #HEOR #HRQoL #pediatrics
New research using US claims data evaluates whether a digital back-pain program reduces subsequent spinal imaging, compared with usual care. #HEOR #BackPain #DigitalHealth
November 17, 2025 at 5:58 PM
New research using US claims data evaluates whether a digital back-pain program reduces subsequent spinal imaging, compared with usual care. #HEOR #BackPain #DigitalHealth
New in JHEOR: Digital cognitive behavioral therapy for insomnia significantly reduced healthcare costs by $2083 per person annually, offering a cost-effective alternative to traditional treatments and improving treatment accessibility. #HEOR #insomnia #CBT #DigitalTherapy
November 13, 2025 at 8:26 PM
New in JHEOR: Digital cognitive behavioral therapy for insomnia significantly reduced healthcare costs by $2083 per person annually, offering a cost-effective alternative to traditional treatments and improving treatment accessibility. #HEOR #insomnia #CBT #DigitalTherapy
New in JHEOR: High clinical event rates and monthly costs among U.S. patients with metastatic triple-negative breast cancer on chemotherapy underscore need for safer, more effective treatment options. #HEOR #mTNBC #BreastCancer #TripleNegative
November 6, 2025 at 3:27 PM
New in JHEOR: High clinical event rates and monthly costs among U.S. patients with metastatic triple-negative breast cancer on chemotherapy underscore need for safer, more effective treatment options. #HEOR #mTNBC #BreastCancer #TripleNegative
Reposted by Journal of Health Economics and Outcomes Research
WHO too reliant on funding from donor organizations, paper argues
Researchers say reliance on earmarked voluntary contributions from external donors like the Gates Foundation undermines the WHO's independence.
www.cidrap.umn.edu/p...
Researchers say reliance on earmarked voluntary contributions from external donors like the Gates Foundation undermines the WHO's independence.
www.cidrap.umn.edu/p...
October 30, 2025 at 5:42 PM
WHO too reliant on funding from donor organizations, paper argues
Researchers say reliance on earmarked voluntary contributions from external donors like the Gates Foundation undermines the WHO's independence.
www.cidrap.umn.edu/p...
Researchers say reliance on earmarked voluntary contributions from external donors like the Gates Foundation undermines the WHO's independence.
www.cidrap.umn.edu/p...
Reposted by Journal of Health Economics and Outcomes Research
Hitting rheumatoid arthritis early and hard, with targeted therapies as first-line treatment, appears to reduce the likelihood that it will reach the dreaded "difficult-to-treat" stage, according to studies.
https://www.medpagetoday.com/meetingcoverage/acr/118195
https://www.medpagetoday.com/meetingcoverage/acr/118195
Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?
Studies suggest strategies that may help
www.medpagetoday.com
October 30, 2025 at 7:45 PM
Hitting rheumatoid arthritis early and hard, with targeted therapies as first-line treatment, appears to reduce the likelihood that it will reach the dreaded "difficult-to-treat" stage, according to studies.
https://www.medpagetoday.com/meetingcoverage/acr/118195
https://www.medpagetoday.com/meetingcoverage/acr/118195
New study in JHEOR evaluates the cost savings for NHS England from switching inappropriate long-term PPI users to episodic alginate therapy. #HEOR #GERD #NHSEngland
October 30, 2025 at 8:33 PM
New study in JHEOR evaluates the cost savings for NHS England from switching inappropriate long-term PPI users to episodic alginate therapy. #HEOR #GERD #NHSEngland
New study in JHEOR evaluates how accurately an LLM could assess economic study quality using the CHEERS checklist, compared with human reviewers. #LLM #HEOR #LargeLanguageModels #CHEERS #HealthEconomics
October 24, 2025 at 2:12 PM
New study in JHEOR evaluates how accurately an LLM could assess economic study quality using the CHEERS checklist, compared with human reviewers. #LLM #HEOR #LargeLanguageModels #CHEERS #HealthEconomics
New study estimates healthcare costs of non-HIV comorbidities in people living with HIV in Spain, highlighting the growing financial and clinical impact of toxicity with antiretroviral therapies. #HIV #HEOR #PLWH #antiretrovirals
October 23, 2025 at 6:17 PM
New study estimates healthcare costs of non-HIV comorbidities in people living with HIV in Spain, highlighting the growing financial and clinical impact of toxicity with antiretroviral therapies. #HIV #HEOR #PLWH #antiretrovirals